Bipolar Disorder Type II (ICD-11: 6A61): Complete Coding and Diagnostic Guide
1. Introduction
Bipolar Disorder Type II is a chronic and recurrent psychiatric condition that significantly affects patients' quality of life. It is characterized by an episodic pattern of mood alterations, where periods of hypomania alternate with depressive episodes, never reaching the severity of a full manic episode. This distinction is fundamental for correct diagnosis and differentiation from Bipolar Disorder Type I.
The clinical importance of Bipolar Disorder Type II lies in the fact that it is frequently underdiagnosed or confused with unipolar depression, since patients typically seek care during depressive episodes, which tend to be more prolonged and disabling. Hypomanic episodes, because they do not cause marked functional impairment and are sometimes perceived as periods of increased productivity, rarely prompt medical consultation, hindering recognition of the bipolar pattern.
The impact on public health is considerable, with high costs related to loss of productivity, absenteeism, hospitalizations, and prolonged treatments. The condition is associated with high suicide risk, psychiatric and medical comorbidities, as well as significant impairment in interpersonal relationships and occupational performance.
Correct coding is critical to ensure appropriate treatment, suitable therapeutic planning, resource allocation, epidemiological research, and effective communication among healthcare professionals. Incorrect use of codes can lead to inadequate treatments, such as monotherapy with antidepressants without mood stabilizers, potentially inducing hypomanic episodes or accelerating mood cycling.
2. Correct ICD-11 Code
Code: 6A61
Description: Bipolar disorder type II
Parent category: Bipolar disorder or related disorders
Official definition: Bipolar Disorder Type II is an episodic mood disorder defined by the occurrence of one or more hypomanic episodes and at least one depressive episode. A hypomanic episode is a persistent mood state lasting for at least several days, characterized by persistent elevation of mood or increased irritability, as well as increased activity or a subjective experience of increased energy, accompanied by other characteristic symptoms, such as increased talkativeness, rapid or racing thoughts, increased self-esteem, decreased need for sleep, distractibility, and impulsive or reckless behavior.
The symptoms represent a clear change from the individual's typical mood, energy level, and behavior, but crucially are not severe enough to cause marked impairment in social, occupational, or other important areas of functioning. A depressive episode is characterized by a period of depressed mood or decreased interest in activities that occurs for most of the day, nearly every day, for a period of at least two weeks, accompanied by other symptoms such as changes in appetite or sleep, agitation or psychomotor retardation, fatigue, feelings of worthlessness or excessive guilt, feelings of hopelessness, difficulty concentrating, and suicidality. There is no history of manic or mixed episodes.
3. When to Use This Code
Code 6A61 should be used in specific clinical situations where the characteristic episodic pattern is clearly documented:
Scenario 1: Patient with history of recurrent depression and episodes of increased productivity A 32-year-old female patient in treatment for depression for five years reports that, between depressive episodes, she experiences periods of four to seven days where she sleeps only four hours per night without feeling tired, initiates multiple projects simultaneously, talks excessively, and feels exceptionally creative and confident. These periods do not impair her work; on the contrary, she is frequently praised for her productivity. History confirms at least two hypomanic episodes and three major depressive episodes over the past five years, without manic episodes.
Scenario 2: Retrospective diagnosis after antidepressant treatment failure A 45-year-old male patient with previous diagnosis of recurrent major depression does not respond adequately to antidepressant monotherapy. During detailed evaluation, he reveals history of periods where he feels "energized," with racing thoughts, reduced need for sleep (three to four hours), increased spending, and more socially disinhibited behavior, lasting five to ten days. These episodes did not cause serious problems, but are clearly different from his usual state. The pattern of at least one hypomanic episode and recurrent depressive episodes justifies code 6A61.
Scenario 3: Young patient with first depressive episode and hypomanic history A 24-year-old student presents with first major depressive episode lasting three months. During careful history taking, a previous episode is identified at age 22, lasting six days, characterized by elevated mood, decreased need for sleep, increased sociability, multiple simultaneous romantic relationships, and increased spending, but without significant academic impairment. The combination of current depressive episode and history of hypomania indicates 6A61.
Scenario 4: Differentiation after observed hypomanic episode A female patient being followed in outpatient care for anxiety disorder presents sudden behavioral change: becomes excessively talkative, initiates artistic projects, reduces sleep to three hours per night, presents increased irritability and sexually disinhibited behavior for one week. The episode resolves spontaneously, followed by a three-week depressive period. Direct observation of the hypomanic episode, without psychotic features or need for hospitalization, combined with subsequent depressive episode, confirms 6A61.
Scenario 5: Positive family history with clear episodic pattern A 38-year-old patient with family history of bipolar disorder presents a pattern of three depressive episodes over the past six years, interspersed with periods of five to eight days of elevated mood, inflated self-esteem, grandiose projects (but not delusional), talkativeness, and reduced sleep. Family members confirm noticeable behavioral changes during these periods, but the patient maintained occupational functioning. Documentation of recurrent pattern with at least two hypomanic episodes and three depressive episodes justifies 6A61.
Scenario 6: Patient with comorbidities where bipolar pattern is identified A 29-year-old female patient in treatment for substance use disorder reveals, during periods of abstinence, an episodic pattern of mood alterations independent of substance use. History identifies hypomanic episodes characterized by increased energy, racing thoughts, and impulsive behavior, alternating with prolonged depressive episodes. Identification of the underlying bipolar pattern, even in the presence of comorbidities, requires appropriate coding with 6A61 as primary or additional diagnosis.
4. When NOT to Use This Code
Code 6A61 should not be used in various situations where alternative diagnoses are more appropriate:
Presence of complete manic episode: If the patient experienced any episode with manic symptoms severe enough to cause marked impairment in functioning, need for hospitalization, or presence of psychotic symptoms, the correct diagnosis is Bipolar Disorder Type I (6A60), not 6A61. The fundamental difference is the severity and functional impact of mood elevation episodes.
Hypomanic symptoms induced by substances or medications: When mood elevation episodes occur exclusively during use of psychoactive substances, antidepressant medications, corticosteroids, or other medications, substance-induced mood disorder should be considered, not 6A61. It is necessary to establish that episodes occur independently of substance use.
Cyclothymia without complete major depressive episodes: Patients with chronic mood fluctuations involving numerous hypomanic periods and depressive periods that do not meet full criteria for major depressive episode should receive code 6A62 (Cyclothymic Disorder). The presence of at least one complete major depressive episode is essential for 6A61.
Unipolar depression with mixed features: Some depressive episodes may present with activated symptoms such as agitation, racing thoughts, or increased energy, without constituting a complete hypomanic episode. These cases should be coded as depressive disorder with appropriate specifier, not as 6A61.
Personality disorders with affective instability: Conditions such as borderline personality disorder may present with rapid mood changes, but without the characteristic episodic pattern with adequate duration and complete hypomanic symptoms. Differentiation requires careful evaluation of duration, pattern, and specific symptoms.
General medical conditions causing symptoms: Hyperthyroidism, multiple sclerosis, brain lesions, and other medical conditions may produce similar symptoms. When symptoms are directly attributable to the medical condition, the appropriate code is mood disorder due to medical condition, not 6A61.
5. Step-by-Step Coding Process
Step 1: Assess diagnostic criteria
Diagnostic confirmation requires systematic and detailed evaluation. Begin with a structured clinical interview exploring complete longitudinal history of mood changes. Specifically investigate episodes of mood elevation, increased energy or irritability, questioning about changes in sleep, thoughts, activity and behavior. Use validated instruments such as the Mood Disorder Questionnaire (MDQ) for screening and the Structured Clinical Interview for DSM/ICD for diagnostic confirmation.
Carefully document the duration of episodes, frequency, specific symptoms and functional impact. Interview collateral informants whenever possible, as patients frequently do not recognize hypomanic episodes as problematic. Assess detailed family history, as bipolar disorders present a strong genetic component.
Confirm the presence of at least one hypomanic episode lasting a minimum of several days (typically four or more), characterized by clear change from baseline mood, increased energy and at least three additional symptoms (four if mood is only irritable). Verify that symptoms did not cause severe functional impairment, did not require hospitalization and did not include psychotic features.
Confirm the presence of at least one complete major depressive episode, lasting a minimum of two weeks, with depressed mood or anhedonia, plus four additional symptoms (sleep changes, appetite, energy, concentration, feelings of guilt or worthlessness, suicidal thoughts). Exclude medical causes through appropriate laboratory tests, including thyroid function, and rule out substance use as the primary cause of symptoms.
Step 2: Verify specifiers
ICD-11 allows specification of the current episode: depressive, hypomanic or in remission. Document the severity of the current episode using criteria of symptom intensity and functional impairment. Identify special features such as prominent anxiety symptoms, mixed features or rapid cycling pattern (four or more episodes per year).
Assess the presence of psychotic symptoms during depressive episodes, which can occur even in Type II. Document seasonal pattern if episodes follow temporal regularity. Record psychiatric comorbidities such as anxiety disorders, substance use or eating disorders, which are frequent and influence prognosis and treatment.
Step 3: Differentiate from other codes
6A60 - Bipolar Disorder Type I: The fundamental difference is the presence of at least one complete manic episode in Type I. Manic episodes cause marked functional impairment, frequently require hospitalization and may include psychotic symptoms. If there is doubt about the severity of any episode, carefully review the functional impact: job loss, hospitalization, behaviors with serious consequences (massive spending, extreme risky sexual behavior, irreversible harmful decisions) indicate complete mania and code 6A60.
6A62 - Cyclothymic Disorder: Characterized by chronic mood instability with numerous hypomanic periods and depressive periods that do not meet full criteria for major depressive episode. The minimum duration is two years in adults. If the patient presented at least one complete major depressive episode, the diagnosis is 6A61, not 6A62. Cyclothymia represents milder yet chronic fluctuation, while 6A61 involves complete and well-defined episodes.
Depressive disorders: Recurrent unipolar depression does not include hypomanic episodes. Differentiation requires active investigation of hypomania history, which is frequently not reported spontaneously. Specifically question about periods of increased energy, elevated productivity, reduced need for sleep and behavioral changes between depressive episodes.
Step 4: Required documentation
Thoroughly record each identified episode, including age of onset, duration, specific symptoms, identifiable precipitants, treatments received and therapeutic response. Document functional impact of each episode in specific areas: work, relationships, finances, physical health.
Include information from collateral informants, especially regarding hypomanic episodes. Record complete family history of mood and psychotic disorders. Document current and previous medication use, including response to antidepressants (hypomanic switch suggests bipolarity). Record medical and psychiatric comorbidities. Maintain a record of mood assessment scales over time, creating an objective longitudinal history.
6. Complete Practical Example
Clinical Case
A 35-year-old female patient, a teacher, seeks psychiatric care reporting "depression that does not improve." She reports that for eight years she has experienced recurrent episodes of profound sadness, loss of interest in activities, difficulty concentrating, initial insomnia, intense fatigue, and thoughts of death, lasting two to four months. She has already undergone three treatment attempts with different antidepressants, with partial and temporary improvement.
During detailed history taking, when questioned about periods of elevated mood or increased energy, she initially denies them. After specific questioning about periods when she felt "exceptionally well" or "energized," she recalls that between depressive episodes she usually experiences periods of five to seven days where she "feels electric": she sleeps only three to four hours per night without fatigue, wakes up with multiple ideas for school projects, speaks very rapidly (colleagues comment on this), feels confident and capable, initiates complete reorganizations at home, makes impulsive purchases (although not excessive enough to cause serious financial problems), and experiences racing thoughts.
The patient reports that during these periods she feels "finally normal" and productive, managing to complete accumulated tasks. She does not consider them problematic, except for family comments about being "agitated" or "talking too much." She denies psychotic symptoms, has never been hospitalized for these episodes, maintains professional functioning, and does not make decisions with serious irreversible consequences. She identifies at least four complete major depressive episodes in the past eight years and approximately six periods of "increased energy" interspersed.
Her husband, interviewed separately, confirms cyclical behavioral changes: periods where she "cannot sit still," talks excessively, sleeps little, initiates multiple projects and becomes irritable when contradicted, lasting about a week, followed by periods where she "does not get out of bed," cries easily and loses interest in everything, lasting months. He confirms that during periods of increased energy she maintains professional responsibilities, although she becomes "more accelerated."
Family history reveals a mother with a diagnosis of bipolar disorder and a maternal uncle with severe depression. Laboratory tests (complete blood count, thyroid function, electrolytes) are within normal limits. There is no current or historical use of psychoactive substances.
Step-by-Step Coding
Criteria analysis:
Hypomanic episodes identified: at least six episodes lasting five to seven days, characterized by elevated/irritable mood, decreased need for sleep (three to four hours without fatigue), increased talkativeness, racing thoughts, increased self-esteem, increased goal-directed activity, impulsive behavior (shopping). Symptoms represent clear change from baseline functioning, confirmed by collateral informant. Crucially, they did not cause marked functional impairment, there was no hospitalization, there were no psychotic symptoms.
Depressive episodes identified: at least four episodes lasting two to four months, characterized by depressed mood, anhedonia, insomnia, fatigue, difficulty concentrating, thoughts of death, lasting longer than two weeks and with significant functional impact.
Absence of manic episodes: no episode with sufficient severity to cause marked functional impairment, require hospitalization, or include psychotic symptoms.
Code chosen: 6A61 - Bipolar Disorder Type II
Complete justification:
The clinical pattern presented meets criteria for Bipolar Disorder Type II by the presence of multiple hypomanic episodes (characterized by typical symptoms with adequate duration, without marked functional impairment) and multiple complete major depressive episodes, without history of manic episodes. The history of inadequate response to antidepressants in monotherapy is consistent with unrecognized bipolarity. The positive family history reinforces the diagnosis.
Differentiation from 6A60 (Type I) is clear by the absence of episodes with sufficient severity to cause marked impairment. Differentiation from 6A62 (Cyclothymia) is established by the presence of complete major depressive episodes, not just subsyndromal depressive periods. Differentiation from recurrent unipolar depression is established by the identification of hypomanic episodes, which were not recognized in previous treatments.
Complementary codes:
Codes may be added to specify current episode (depressive, hypomanic, or in remission) and identified comorbidities, if present. In this case, if the patient is in a depressive episode at the time of evaluation, this should be documented. Comorbidities such as anxiety disorders, if present, should receive additional coding.
7. Related Codes and Differentiation
Within the Same Category
6A60: Bipolar Disorder Type I
When to use 6A60: Use this code when the patient has presented with at least one complete manic episode, characterized by symptoms severe enough to cause marked impairment in social, occupational, or other important areas of functioning, or need for hospitalization to prevent harm to self or others, or presence of psychotic symptoms.
Main difference: The fundamental distinction between 6A60 and 6A61 lies in the severity of mood elevation episodes. In Type I, there is complete mania with severe functional impairment, potential need for hospitalization, and possible psychotic symptoms. In Type II, hypomanic episodes do not reach this severity, allowing maintenance of basic functioning, without need for hospitalization, and without psychotic symptoms. Both may present with severe depressive episodes, but the presence of a single complete manic episode defines Type I permanently.
6A62: Cyclothymic Disorder
When to use 6A62: Use this code for patients with persistent mood instability for at least two years in adults, involving numerous periods with hypomanic symptoms and numerous periods with depressive symptoms, without meeting full criteria for hypomanic episode or major depressive episode.
Main difference: Cyclothymia represents chronic and less severe mood fluctuations, without complete episodes. If the patient has presented with at least one complete major depressive episode (two weeks with sufficient symptoms) or complete hypomanic episode (several days with sufficient symptoms and clear functional change), the diagnosis progresses to 6A61 or 6A60, not remaining as 6A62. Cyclothymia is considered a milder and chronic form, while 6A61 involves distinct and more severe episodes, especially depressive ones.
Differential Diagnoses
Recurrent Depressive Disorder: Differentiated by the absence of hypomanic episodes. Active investigation of hypomania history is essential, as patients rarely report it spontaneously. Inquire about periods of increased energy, elevated productivity, and reduced need for sleep between depressive episodes.
Borderline Personality Disorder: May present with affective instability, but mood changes are typically reactive to interpersonal events, short-lived (hours, not days), and without the characteristic episodic pattern with complete hypomanic symptoms. Differentiation requires careful assessment of duration, temporal pattern, and presence of specific symptoms.
Substance-Induced Mood Disorder: When symptoms occur exclusively during intoxication or withdrawal from substances. Establish whether episodes occurred independently of substance use through detailed longitudinal history.
Attention-Deficit/Hyperactivity Disorder (ADHD): May share symptoms such as distractibility, impulsivity, and increased activity, but in ADHD symptoms are chronic since childhood, not episodic. The episodic nature with periods of normal functioning differentiates 6A61 from ADHD.
8. Differences with ICD-10
In ICD-10, the closest equivalent code is F31.8 (Other bipolar affective disorders) or F31.9 (Bipolar affective disorder, unspecified), since ICD-10 does not have a specific code dedicated exclusively to Bipolar Disorder Type II. Some systems used F31 with additional specifiers to indicate the Type II pattern.
The main change in ICD-11 is the explicit recognition of Bipolar Disorder Type II as a distinct diagnostic category with its own code (6A61), reflecting decades of research demonstrating diagnostic validity, specific clinical pattern, distinct course, and particular therapeutic implications. This change facilitates identification, precise coding, epidemiological research, and communication among professionals.
ICD-11 also provides clearer and operationalized definitions of criteria for hypomanic and depressive episodes, facilitating consistent clinical application. The clearer hierarchical structure, with well-defined categories within bipolar disorders, improves navigation and selection of the appropriate code.
The practical impact of these changes includes better recognition of Bipolar Disorder Type II, which historically was underdiagnosed. Specific coding allows more precise epidemiological tracking, planning of adequate services, and development of specific therapeutic guidelines. For professionals, the transition requires familiarization with the new structure, but results in more accurate documentation and more effective communication.
9. Frequently Asked Questions
How is Bipolar Disorder Type II diagnosed?
The diagnosis is essentially clinical, based on detailed interview exploring complete longitudinal history of mood alterations. There are no laboratory or imaging tests that confirm the diagnosis. The professional must actively investigate episodes of mood elevation, as patients rarely report them spontaneously. Use of structured instruments such as screening questionnaires and standardized diagnostic interviews increases accuracy. Information from family members or close persons is valuable, especially for characterizing hypomanic episodes. Laboratory tests are used to exclude medical causes (such as thyroid dysfunction) that may mimic symptoms. The evaluation requires adequate time, frequently multiple consultations, to establish episodic pattern over years.
Is treatment available in public health systems?
Treatment for Bipolar Disorder Type II is generally available in public health systems in most countries, although access may vary. Treatment typically involves mood stabilizers such as lithium, anticonvulsants (valproate, lamotrigine, carbamazepine) and atypical antipsychotics, which are included in essential medication lists. Psychotherapy, especially cognitive-behavioral therapy and psychoeducation, are important components of treatment. The availability of specialized professionals and access to psychotherapy may be more limited in some regions. Mental health care programs in public services generally include management of bipolar disorders, although the quality and comprehensiveness of services vary. Patients should seek specific information about resources available in their local health systems.
How long does treatment last?
Bipolar Disorder Type II is a chronic condition that typically requires long-term treatment, often for life. After initial stabilization, which may take weeks to months, maintenance treatment is essential to prevent recurrences. Studies demonstrate that discontinuation of medications is associated with high risk of relapse. The minimum recommended duration of pharmacological treatment after stabilization is generally several years, and many patients benefit from indefinite treatment. Psychotherapy may be conducted more intensively initially and subsequently with reduced frequency for maintenance. Decisions about treatment duration should be individualized, considering number of previous episodes, severity, treatment response, and patient preferences. Regular monitoring is necessary even during periods of stability.
Can this code be used in medical certificates?
The use of diagnostic codes in medical certificates varies according to local regulations and specific context. In many jurisdictions, medical certificates to justify absences from work or school do not require detailed diagnostic specification, being sufficient to indicate need for leave due to health reasons. When diagnostic specification is necessary or requested, code 6A61 may be used, although some professionals prefer more generic terms to preserve patient privacy. For documentation in health systems, medical records, and communication between professionals, the specific code should be used to ensure continuity of care. Patients have the right to confidentiality, and disclosure of specific diagnostic information must respect ethical and legal principles of privacy.
What is the difference between hypomania and mania?
The fundamental difference is severity and functional impact. Hypomania involves symptoms of mood elevation, increased energy, decreased need for sleep, racing thoughts and more impulsive behavior, but without causing marked functional impairment. Hypomanic patients generally maintain social and professional functioning, may even present increased productivity, and do not require hospitalization. Mania involves more severe symptoms that cause significant impairment in functioning, frequently require hospitalization, may include psychotic symptoms (delusions, hallucinations) and result in serious consequences such as job loss, legal or severe financial problems. Duration also differs: hypomania lasts at least several days (typically four or more), while mania requires minimum duration of one week or hospitalization. The presence of psychotic symptoms automatically defines the episode as manic, not hypomanic.
Can people with Bipolar Disorder Type II work normally?
Many people with Bipolar Disorder Type II maintain adequate professional functioning, especially when receiving appropriate treatment and achieving stabilization. During periods of remission, functioning can be completely normal. During depressive episodes, there may be need for temporary leave or adjustments in responsibilities. Hypomanic episodes typically do not prevent work, and may even result in temporarily increased productivity, although the quality of decisions may be compromised. Occupational prognosis improves significantly with appropriate treatment, including medications and psychotherapy. Some people may benefit from reasonable adjustments in the work environment, such as schedule flexibility during periods of greater difficulty. The ability to work varies individually according to severity, frequency of episodes, treatment response, and nature of professional demands.
Can Bipolar Disorder Type II progress to Type I?
Although most patients with a diagnosis of Bipolar Disorder Type II maintain this pattern throughout life, a minority may eventually present a complete manic episode, at which point the diagnosis is reclassified as Type I. Studies suggest this occurs in approximately 5 to 15% of cases over years of follow-up. Risk factors include early onset, family history of Type I, and use of antidepressants without mood stabilizers. It is important to note that once a complete manic episode has occurred, the diagnosis remains as Type I even if subsequent episodes are only hypomanic or depressive. Appropriate treatment with mood stabilizers may reduce the risk of progression. Regular monitoring allows early identification of symptoms that may be progressing to complete mania, allowing rapid intervention.
What are the risks if Bipolar Disorder Type II is not treated?
Untreated Bipolar Disorder Type II is associated with significant risks. The risk of suicide is elevated, comparable to or even higher than Type I in some studies, especially during depressive episodes. Recurrent episodes may result in progressive impairment of social, occupational, and family functioning. Comorbidities are frequent, including anxiety disorders, substance use, and medical conditions such as cardiovascular and metabolic diseases. Quality of life becomes significantly compromised. Interpersonal relationships may be harmed by mood fluctuations and behaviors during episodes. Decisions made during hypomanic episodes may have financial or legal consequences. Appropriate treatment substantially reduces these risks, prevents recurrences, improves functioning and quality of life. Early intervention is associated with better long-term prognosis, reinforcing the importance of correct diagnosis and timely treatment initiation.
Conclusion: Code 6A61 for Bipolar Disorder Type II in ICD-11 represents an important advance in the recognition of this specific condition, facilitating precise diagnosis, appropriate treatment, and effective communication between professionals. Correct coding requires clear understanding of diagnostic criteria, careful differentiation of similar conditions, and detailed documentation of the characteristic episodic pattern. Proper recognition of Bipolar Disorder Type II allows implementation of appropriate therapeutic strategies, including mood stabilizers and psychotherapy, significantly improving patient prognosis and quality of life.
External References
This article was prepared based on reliable scientific sources:
- 🌍 WHO ICD-11 - Bipolar disorder type II
- 🔬 PubMed Research on Bipolar disorder type II
- 🌍 WHO Health Topics
- 📋 NICE Mental Health Guidelines
- 📊 Clinical Evidence: Bipolar disorder type II
- 📋 Ministry of Health - Brazil
- 📊 Cochrane Systematic Reviews
References verified on 2026-02-02